The company informed exchanges that the board of directors will meet on June 24, 2022, to consider raising of funds through the issue of sh...

Shares of Suven Life have soared about 25 per cent in the last one month. In the last one year, the company has delivered over 65 per cent ...

Buy Suven Life Sciences at a price target of Rs 287 and a stop loss at Rs 228.

Buy Suven Life Sciences Ltd. at a price target of Rs 270.0 .

The molecules are being developed for the treatment of cognitive impairment associated with neuro-degenerative disorders like Alzheimer's d...

"Suven Life Sciences Ltd. is a 'BUY' call with a target of Rs 298 and a stop loss of Rs 282"

"Suven Life Sciences Ltd is a 'BUY' call with a target of Rs 282 and a stop loss of Rs of 260"

'Suven Life Sciences Ltd. is a 'BUY' call with a target of Rs 272 and a stop loss of Rs 256'

Suven Life Sciences Ltd is a 'BUY' call with a target of Rs 280 and a stop loss of Rs 262.

Suven Life Sciences today said it has been granted a patent by Israel, Japan and South Africa for a drug used to treat neuro-degenerative d...

Suven Life Sciences surged as much as 6.97% after the co secured five product patents in Israel, Japan, China and New Zealand for NCEs.

At 09:50 a.m.; Suven Life Sciences was trading 1.8 per cent higher at Rs 223.95. It hit a low of Rs 221.75 and a high of Rs 225.50 in trade...

Suven Life Sciences is a 'BUY' call with a target of Rs 212 and a stop loss of Rs 194.

Suven Life Sciences Ltd net profit rise by 137% for Q1. Company to go ahead with amalgamation of Suven Nishtaa Pharma Pvt Ltd with Suven Li...

Shares of Suven Life Sciences gained around 5% after the company secured four overseas product patents.

Suven Life Sciences clinical drug candidate SUVN- 502, meant for treatment of Alzheimer’s disease and Schizophrenia, has successfully compl...

Shares of Suven Life Sciences gained momentum after the company secured four product patents, two each from New Zealand and Eurasia corresp...